Hands‑Free AI Reading Now Live in U.S. Radiology Practices

Hands‑Free AI Reading Now Live in U.S. Radiology Practices

Coreline Soft has partnered with INFINITT North America to embed its AVIEW AI platform directly into the INFINITT PACS environment. The result is a fully automated, zero‑click AI reading solution now live in U.S. radiology practices. Radiologists can access AI‑powered insights without extra logins or workflow interruptions, making advanced technology part of everyday clinical practice.

Clay Hinrichs, President of ImageCare Radiology, the first U.S. site to adopt the solution, said the rollout took just one month and immediately improved both speed and accuracy. For high‑volume groups handling thousands of cases per quarter, the platform has boosted sensitivity, reduced reading times, and even driven more follow‑up exams, translating into measurable revenue growth.

Integration suite for U.S. practices

To support adoption, Coreline has launched the INFINITT Integration Suite. It enables rapid deployment of AI modules, supports CPT‑based reimbursement, and delivers a hands‑free experience for clinicians. Radiologists can focus on patient care while AI works in the background.

Looking ahead at STR 2026

At the upcoming Society of Thoracic Radiology meeting, Coreline will showcase its chest AI portfolio. AVIEW LCS has redefined the “First Reader” role in lung cancer screening, while AVIEW Lung Texture and AVIEW COPD highlight opportunistic screening, assessing lung cancer, COPD, and cardiovascular risk from a single low‑dose CT scan.

About Coreline Soft

Coreline Soft develops clinically optimized AI solutions for thoracic imaging. Its AVIEW platform supports lung cancer screening, COPD assessment, and calcium scoring, with integrations designed to fit seamlessly into existing radiology workflows. By combining advanced AI with practical deployment, Coreline helps radiologists deliver faster, more accurate care.

Forward-looking information is subject to risks and uncertainties. Please read our full Disclaimer.

Join our Mailing List

Sign up and receive carefully curated updates on our latest stock picks, investment recommendations, company spotlights, and in-depth market analysis.

Name

By submitting your information, you’re giving us permission to email you. No spam, no excessive emails. You may unsubscribe at any time.